BAP31 Facilitates TGF-β Trafficking and Secretion and Promotes Dendritic Cell Dysfunction in Cervical Cancer
Cells · 2026
DOI: 10.3390/cells15191765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Lin Guo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Air Force Medical University, No. 169 Changle West Road, Xi'an 710032, China. Hauptthemen laut MEDLINE: Dendritic Cells, Uterine Cervical Neoplasms, Transforming Growth Factor beta, Membrane Proteins. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Laboratory Special Research Project of Shaanxi Provincial Basic Natural Science Research Program, Clinical Research Support Program of Air Force Medical University.
Abstract (Originalsprache)
Cervical cancer remains one of the major gynecological malignancies worldwide, with tumor immune evasion playing a critical role in disease progression. Although accumulating evidence has implicated BAP31 in tumor progression and immune regulation, its role in immune evasion in cervical cancer remains poorly understood. In this study, we found that BAP31 was significantly upregulated in cervical cancer tissues and that elevated BAP31 expression was associated with poor patient prognosis. Functional assays demonstrated that BAP31 silencing restored the immune activity of dendritic cells. Mechanistically, BAP31 was found to regulate TGF-β at the post-transcriptional level and to facilitate its transport from the endoplasmic reticulum to the Golgi apparatus through an interaction involving the Asn-381 residue, thereby affecting its intracellular maturation and extracellular secretion. Additional functional analyses showed that exogenous TGF-β impaired dendritic cell maturation and migration while enhancing phagocytic activity. Collectively, these findings indicate that BAP31 regulation of TGF-β contributes to dendritic cell dysfunction and the establishment of an immunosuppressive microenvironment in cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Air Force Medical University, No. 169 Changle West Road, Xi'an 710032, China.
- Yan'an Key Laboratory of Microbial Drug Innovation and Transformation, School of Basic Medicine, Yan'an University, Yan'an 716000, China.
- School of Medicine, Northwest University, Xi'an 710069, China.
- School of Basic Medicine, Air Force Medical University, No. 169 Changle West Road, Xi'an 710032, China.
- Military Medical Innovation Center, Air Force Medical University, Xi'an 710032, China.
ORCID-Profile: Shuya Yang
Förderung
- National Natural Science Foundation of China
- Key Laboratory Special Research Project of Shaanxi Provincial Basic Natural Science Research Program
- Clinical Research Support Program of Air Force Medical University
- Youth Talent Elevation Program of Shaanxi Provincial Association for Science and Technology
- Young Talent Fund of Association for Science and Technology in Shaanxi, China
Zitieren
APA
Guo, L., He, Y., Hu, F., Sun, Y., Zhang, Y., Ren, J., Zheng, R., Zhang, J., Sun, Y., Cai, S., Wang, Y., Yang, K., Hu, C., & Yang, S. (2026). BAP31 Facilitates TGF-β Trafficking and Secretion and Promotes Dendritic Cell Dysfunction in Cervical Cancer. Cells. https://doi.org/10.3390/cells15191765
Vancouver
Guo L, He Y, Hu F, Sun Y, Zhang Y, Ren J, et al. BAP31 Facilitates TGF-β Trafficking and Secretion and Promotes Dendritic Cell Dysfunction in Cervical Cancer. Cells. 2026. doi:10.3390/cells15191765
BibTeX
@article{Guo2026,
author = {Guo, Lin and He, Yuanli and Hu, Feiming and Sun, Yuanjie and Zhang, Yajie and Ren, Junyi and Zheng, Ren and Zhang, Junqi and Sun, Yubo and Cai, Sirui and Wang, Yueyue and Yang, Kun and Hu, Chenchen and Yang, Shuya},
title = {BAP31 Facilitates TGF-β Trafficking and Secretion and Promotes Dendritic Cell Dysfunction in Cervical Cancer},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15191765}
}
EUVIMED